XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Defecit)
Balance at beginning of period (in shares) at Dec. 31, 2021   103,437    
Balance at beginning of period at Dec. 31, 2021 $ 826,302 $ 103 $ 844,829 $ (18,630)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation cost 11,364   11,364  
Issuance of equity awards, net (in shares)   562    
Issuance of equity awards, net 420 $ 1 419  
Tax withholdings paid for net settlement of equity awards (2,691)   (2,691)  
Net income (loss) 11,817     11,817
Balance at end of period (in shares) at Mar. 31, 2022   103,999    
Balance at end of period at Mar. 31, 2022 847,212 $ 104 853,921 (6,813)
Balance at beginning of period (in shares) at Dec. 31, 2021   103,437    
Balance at beginning of period at Dec. 31, 2021 826,302 $ 103 844,829 (18,630)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (21,043)      
Balance at end of period (in shares) at Jun. 30, 2022   104,308    
Balance at end of period at Jun. 30, 2022 817,036 $ 104 856,605 (39,673)
Balance at beginning of period (in shares) at Mar. 31, 2022   103,999    
Balance at beginning of period at Mar. 31, 2022 847,212 $ 104 853,921 (6,813)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation cost 3,458   3,458  
Issuance of equity awards, net (in shares)   309    
Issuance of equity awards, net 321   321  
Tax withholdings paid for net settlement of equity awards (1,095)   (1,095)  
Net income (loss) (32,860)     (32,860)
Balance at end of period (in shares) at Jun. 30, 2022   104,308    
Balance at end of period at Jun. 30, 2022 817,036 $ 104 856,605 (39,673)
Balance at beginning of period (in shares) at Dec. 31, 2022   114,515    
Balance at beginning of period at Dec. 31, 2022 954,033 $ 114 970,519 (16,600)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation cost 3,536   3,536  
Issuance of equity awards, net (in shares)   656    
Issuance of equity awards, net 0 $ 1 (1)  
Tax withholdings paid for net settlement of equity awards (3,379)   (3,379)  
Net income (loss) 28,733     28,733
Balance at end of period (in shares) at Mar. 31, 2023   115,171    
Balance at end of period at Mar. 31, 2023 982,923 $ 115 970,675 12,133
Balance at beginning of period (in shares) at Dec. 31, 2022   114,515    
Balance at beginning of period at Dec. 31, 2022 954,033 $ 114 970,519 (16,600)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 67,990      
Balance at end of period (in shares) at Jun. 30, 2023   112,958    
Balance at end of period at Jun. 30, 2023 1,008,359 $ 113 956,856 51,390
Balance at beginning of period (in shares) at Mar. 31, 2023   115,171    
Balance at beginning of period at Mar. 31, 2023 982,923 $ 115 970,675 12,133
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation cost 3,758   3,758  
Issuance of equity awards, net (in shares)   76    
Issuance of equity awards, net 0      
Tax withholdings paid for net settlement of equity awards (4)   (4)  
Share repurchases (in shares)   (2,289)    
Share repurchases (17,470) $ (2) (17,468)  
Excise tax on share repurchases (105)   (105)  
Net income (loss) 39,257     39,257
Balance at end of period (in shares) at Jun. 30, 2023   112,958    
Balance at end of period at Jun. 30, 2023 $ 1,008,359 $ 113 $ 956,856 $ 51,390